Ethacrynic Acid
Specifications
58-54-8CAS Number
200-384-1EC Number
2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acidIUPAC Name
C13H12Cl2O4Chemical Formula
303.13 g/molMolecular Weight
ETHACRYNIC ACID; 58-54-8; Etacrynic Acid; Etacrinic acid; Hydromedin; Taladren; Hidromedin; Crinuryl; Edecril; Edecrina; Endecril; Otacril; Mingit; Reomax; Uregit; Etakrinic acid; Methylenebutyrylphenoxyacetic acid; MK-595; Acido etacrinico; Acide etacrynique; Acidum etacrynicum; [2,3-Dichloro-4-(2-methylenebutyryl)phenoxy]acetic acid; Methylenebutyryl phenoxyacetic acid; (2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid; 2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid; NSC-85791; DTXSID3025257; M5DP350VZV; 2,3-Dichloro-4-(2-methylenebutyryl)phenoxy acetic acid; (2,3-Dichloro-4-(2-methylenebutyryl)phenoxy)acetic acid; (4-(2-Methylenebutyryl)-2,3-dichlorophenoxy)acetic acid; NSC-624008; Acetic acid, (2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy)-; Acetic acid, [2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy]-; [4-(2-Methylenebutyryl)-2,3-dichlorophenoxy]acetic acid; NSC85791; Acetic acid, (2,3-dichloro-4-(2-methylenebutyryl)phenoxy)-; Kyselina 4-(2-(1-butenyl)karbonyl)-2,3-dichlorfenoxyoctova; CHEBI:4876; DTXCID205257; [2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic acid; Acid, Etacrynic; Ethacrinic acid; Ethacrynic Acid, Sodium Salt; 2-(2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy)acetic acid; Acetic acid, [2,3-dichloro-4-(2-methylenebutyryl)phenoxy]-; Acid, Ethacrinic; Acid, Ethacrynic; RefChem:591356; (2,3-Dichloro-4-(2-ethylacryloyl)phenoxy)acetic acid; C03CC01; 200-384-1; ethacrynate; Edecrin; Ethacrinique (acide); Kyselina ethakrynova; Kyselina ethakrynova [Czech]; Acide etacrynique [INN-French]; Acido etacrinico [INN-Spanish]; Acidum etacrynicum [INN-Latin]; 2,3-Dichloro-4-(2-methylenebutyl)phenoxyacetic acid; Crinuril; MK 595; NSC 85791; NSC 624008; BRN 1915060; Etacrynic acid [INN]; [2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid; MFCD00056693; CHEMBL456; Kyselina 4-(2-(1-butenyl)karbonyl)-2,3-dichlorfenoxyoctova [Czech]; MLS000069535; MLS002701928; 2-(2,3-Dichloro-4-(2-methylenebutanoyl)phenoxy)acetic acid; NSC624008; CAS-58-54-8; NCGC00016260-05; 2-[2,3-dichloro-4-(2-methylenebutanoyl)phenoxy]acetic acid; SMR000058600; Ethacryinic Acid; Ethacrynic acid [USAN:BAN]; 2-[2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic acid; CCRIS 4638; HSDB 2136; Ethacrynic acid (USP); SR-01000003010; EINECS 200-384-1; UNII-M5DP350VZV; Etacrynsaure; etacrynic-acid; 58-54-8 (free acid); Ethacrynic acid [USAN:USP]; 2-(2,3-DICHLORO-4-(2-METHYLENE-1-OXOBUTYL)PHENOXY)ACETIC ACID; 1gsf; 2gss; Etacrynic acid CRS; Prestwick_671; 2,3-Dichloro-4-(2-methylenebutyryl)phenoxyacetic acid; Opera_ID_61; Spectrum_000813; Prestwick0_000259; Prestwick1_000259; Prestwick2_000259; Prestwick3_000259; Spectrum2_000097; Spectrum3_000425; Spectrum4_000544; Spectrum5_000680; E0526; bmse000134; Ethacrynic acid (Standard); SCHEMBL26353; BSPBio_000078; BSPBio_002010; ETACRYNIC ACID [JAN]; ETHACRYNIC ACID [MI]; KBioGR_001207; KBioSS_001293; MLS002548854; DivK1c_000900; Etacrynic acid (JP17/INN); SPECTRUM1500287; SPBio_000054; SPBio_002297; ETHACRYNIC ACID [HSDB]; ETHACRYNIC ACID [USAN]; BPBio1_000086; GTPL7179; orb1224584; orb1302754; ETACRYNIC ACID [MART.]; ETHACRYNIC ACID [VANDF]; ETACRYNIC ACID [WHO-DD]; SCHEMBL29384243; HMS502M22; HY-B1640R; KBio1_000900; KBio2_001293; KBio2_003861; KBio2_006429; KBio3_001230; [2,3-dichloro-4-(2-methylenebutanoyl)phenoxy]acetic acid; NINDS_000900; GLXC-02567; HMS1568D20; HMS1920M16; HMS2089N17; HMS2091D17; HMS2095D20; HMS3259G03; HMS3712D20; HMS5084B20; Pharmakon1600-01500287; HY-B1640; MSK10501; Ethacrynic acid, >=97% (HPLC); Tox21_110335; Tox21_201102; BDBM50186231; CCG-38915; EBC-03779; ETACRYNIC ACID [EP IMPURITY]; NSC757026; s5561; WLN: QV1OR BG CG DVY2&U1; ETACRYNIC ACID [EP MONOGRAPH]; ETHACRYNIC ACID [ORANGE BOOK]; GST Inhibitor-2 (Ethacrynic acid)); AKOS003404732; Tox21_110335_1; DB00903; ETHACRYNIC ACID [USP MONOGRAPH]; FE22848; KS-1453; NC00450; NSC-757026; IDI1_000900; NCGC00016260-01; NCGC00016260-02; NCGC00016260-03; NCGC00016260-04; NCGC00016260-06; NCGC00016260-07; NCGC00016260-08; NCGC00016260-09; NCGC00016260-10; NCGC00016260-11; NCGC00016260-13; NCGC00022601-03; NCGC00022601-04; NCGC00022601-05; NCGC00258654-01; Etacrynic acid for system suitability CRS; NCI60_041898; SBI-0051374.P003; DB-053221; AB00051988; CS-0013591; NS00009284; T4564; A51097; D00313; AB00051988-19; AB00051988_20; F822272; Q418571; SR-01000003010-2; SR-01000003010-3; BRD-K63630713-001-05-0; BRD-K63630713-001-15-9; BRD-K63630713-001-25-8; [2,3-Dichloro-4-(2-ethylacryloyl)phenoxy]acetic acid #; 2,3-Dichloro-4-(2-methylenebutanoyl)phenoxyacetic acid; Acetic acid,3-dichloro-4-(2-methylenebutyryl)phenoxy]-; Z1590781983; 2,3-DICHLORO-4-(2-METHYLENEBUTYRYL)PHENOXY)ACETATE; 4-(METHYLENEBUTYRYL)-2,3-DICHLOROPHENOXY)ACETIC ACID; Acetic acid,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy]-; Ethacrynic acid, European Pharmacopoeia (EP) Reference Standard; Ethacrynic acid, United States Pharmacopeia (USP) Reference Standard; Acetic acid, [2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy]- (9CI); Etacrynic acid for system suitability, European Pharmacopoeia (EP) Reference StandardSynonyms
Products Containing Ethacrynic Acid
Ethacrynic Acid - Biophore India Pharmaceuticals Pvt LtdEthacrynic Acid - TopChem PharmaceuticalsEthacrynic Acid - Zydus LifesciencesEthacrynic Acid - Breckenridge PharmaceuticalEthacrynic Acid - ViatrisEthacrynic Acid - Solara Active Pharma SciencesEthacrynic Acid - Sai Life Sciences LimitedEthacrynic Acid
